🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
68.55
-0.58 (-0.84%)
At close: Nov 20, 2026, 4:00 PM EST
68.90
+0.35 (0.51%)
After-hours: Nov 20, 2026, 7:39 PM EST

ANI Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
420.76285.59144.86221.1248.23100.3
Short-Term Investments
15.599.136.31---
Cash & Short-Term Investments
436.97294.72151.17221.1248.23100.3
Cash Growth
60.96%94.96%-31.64%358.49%-51.92%1175.43%
Receivables
304.45281.08221.73162.08165.44128.53
Inventory
136.41143.07136.78111.2105.3681.69
Prepaid Expenses
24.7622.9917.9817.48.397.59
Restricted Cash
0.040.040.03-5.01-
Other Current Assets
0.211.230.778.0211.853.67
Total Current Assets
902.82753.12528.46519.82344.26321.78
Property, Plant & Equipment
81.5562.4856.8644.5943.2552.67
Long-Term Investments
-1.654.96.248.8-
Goodwill
62.4862.4859.9928.2228.2227.89
Other Intangible Assets
433.11479.53541.83209.01251.64294.12
Long-Term Deferred Tax Assets
74.6769.0785.1190.7181.3667.94
Long-Term Deferred Charges
0.50.6----
Other Long-Term Assets
12.5311.467.325.842.567.21
Total Assets
1,5681,4401,284904.42760.09771.6

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
74.4262.5845.6636.6829.3122.97
Accrued Expenses
176.31144.3292.857.8435.8927.89
Current Portion of Long-Term Debt
23.3617.279.170.850.850.85
Current Portion of Leases
-2.03----
Current Income Taxes Payable
8.982.247.528.16--
Other Current Liabilities
45.6549.6739.341.9433.435.83
Total Current Liabilities
328.72278.11194.45145.4899.4487.54
Long-Term Debt
583.87599.77614.92284.82285.67286.52
Long-Term Leases
10.139.22--1.38-
Other Long-Term Liabilities
7.8412.5546.5716.5335.0638.8
Total Liabilities
930.55899.65855.94446.82421.55412.86

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
634.24596.04519.65514.1403.9387.84
Retained Earnings
66.25-23.1-100.28-80.13-97.29-47.77
Treasury Stock
-62.21-33.25-21.04-10.08-5.09-3.14
Comprehensive Income & Other
-1.171.035.348.8612.17-3.06
Total Common Equity
637.11540.72403.68432.75313.69333.89
Shareholders' Equity
637.11540.72428.53457.6338.54358.74
Total Liabilities & Equity
1,5681,4401,284904.42760.09771.6

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
617.36628.28624.09285.67287.9287.37
Net Cash (Debt)
-180.39-333.57-472.92-64.55-239.67-187.07
Net Cash Growth
------
Net Cash Per Share
-8.30-15.71-24.48-3.55-14.74-14.85
Filing Date Shares Outstanding
21.1820.8820.3119.7216.3516.55
Total Common Shares Outstanding
21.3520.9519.6519.1216.3516.12
Working Capital
574.1475.01334374.34244.82234.24
Book Value Per Share
29.8425.8020.5422.6419.1820.71
Tangible Book Value
141.52-1.28-198.14195.5233.8311.88
Tangible Book Value Per Share
6.63-0.06-10.0810.232.070.74
Land
-2.411.581.551.555.95
Buildings
-25.8324.4417.8816.6619.97
Machinery
-76.0468.750.4153.1546.77
Construction In Progress
-8.834.577.694.62.94
Leasehold Improvements
-1.411.3---
SEC Filings: 10-K · 10-Q